Cratylia mollis lectin reduces inflammatory burden induced by multidrug-resistant Staphylococcus aureus in diabetic wounds

Lucas dos Santos Silva,Simeone Júlio dos Santos Castelo Branco,Izadora Souza Soeiro Silva,Miria Yasmim Miranda Paiva,Beatriz Gomes Vila Nova,Carlos Emanuel de Matos Chaves Lima,Weslley Felix de Oliveira,Felipe Eduardo Alves de Paiva,Patrícia Maria Guedes Paiva,Andrea de Souza Monteiro,Claudener Souza Teixeira,Cléver Gomes Cardoso,Maria Tereza dos Santos Correia,Luís Cláudio Nascimento da Silva
DOI: https://doi.org/10.1007/s00418-024-02330-9
2024-11-30
Histochemistry and Cell Biology
Abstract:In diabetes, tissue repair is impaired, increasing susceptibility to Staphylococcus aureus infections, a pathogen commonly found in wounds. The emergence of S. aureus strains that are highly resistant to antimicrobial agents highlights the urgent need for alternative therapeutic options. One promising candidate is Cramoll ( Cratylia mollis seed lectin), known for its immunomodulatory, mitogenic, and healing properties. However, its efficacy in infected diabetic wounds remains unexplored. This study evaluated the effects of topical Cramoll treatment on diabetic wounds infected by S. aureus . Diabetic Swiss mice (induced by streptozotocin) were subjected to an 8-mm wound on the back and subsequently infected with a suspension of multidrug-resistant S. aureus . During the treatment period, the wounds were clinically evaluated for inflammation and the area of injury. After seven days, samples were collected from the wounds to quantify the bacterial load and histopathological and immunological analyses. Wounds infected by S. aureus exhibited more pronounced areas and severity indices, which were significantly reduced by Cramoll treatment ( p < 0.05). Histopathological analysis revealed a reduction in inflammatory cells and an increase in revascularization with Cramoll treatment ( p < 0.05). Cramoll also promoted greater collagen production compared to controls ( p < 0.05). Furthermore, Cramoll treatment significantly reduced the S. aureus load in wounds ( p < 0.0001), decreased TNF-α and IL-6 levels in infected wounds, and increased ERK pathway activation ( p < 0.05). In conclusion, Cramoll lectin improves the healing of diabetic wounds, and these results contribute to the understanding of Cramoll healing mechanisms, reinforcing its potential as a healing agent in various clinical conditions.
cell biology,microscopy
What problem does this paper attempt to address?